Literature DB >> 22183457

Potential utility of hyperbaric oxygen therapy and propolis in enhancing the leishmanicidal activity of glucantime.

Diana Copi Ayres1, Thiago Antonio Fedele, Maria Cristina Marcucci, Selma Giorgio.   

Abstract

In this study we investigated the efficacy of hyperbaric oxygen (HBO) therapy, alone or combined with the pentavalent antimonial glucantime on Leishmania amazonensis infection. In parallel, the effect of Brazilian red propolis gel (propain) alone or combined with glucantime on L. amazonensis infection was evaluated. The inhibition of the infection in macrophages treated with glucantime in combination with HBO exposition was greater than that of macrophages treated with glucantime alone or HBO alone. The susceptible mouse strain BALB/c infected in the shaved rump with L. amazonensis treated with glucantime and exposed to HBO showed: time points in the course of the disease in which lesions were smaller than those of mice treated with glucantime alone and revascularization of the skin in the lesion site; interferon-gamma (IFN-g) levels were not elevated in lymph node cells from these animals. Propain alone was not efficient against lesions, although less exudative lesions were observed in animals treated with propain alone or combined with glucantime. These results reveal the potential value of HBO and red propolis in combination with glucantime for treating cutaneous leishmaniasis and encourage further studies on the effect of more aggressive HBO, propolis and glucantime therapies on different mouse models of leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22183457     DOI: 10.1590/s0036-46652011000600006

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  6 in total

1.  Propolis reduces Leishmania amazonensis-induced inflammation in the liver of BALB/c mice.

Authors:  Suelen S da Silva; Sandra S Mizokami; Jacqueline R Fanti; Milena M Miranda; Natalia Y Kawakami; Fernanda Humel Teixeira; Eduardo J A Araújo; Carolina Panis; Maria A E Watanabe; José M Sforcin; Wander R Pavanelli; Waldiceu A Verri; Ionice Felipe; Ivete Conchon-Costa
Journal:  Parasitol Res       Date:  2015-12-28       Impact factor: 2.289

Review 2.  Promising Anti-Protozoan Activities of Propolis (Bee Glue) as Natural Product: A Review.

Authors:  Shabnam Asfaram; Mahdi Fakhar; Masoud Keighobadi; Javad Akhtari
Journal:  Acta Parasitol       Date:  2020-07-20       Impact factor: 1.440

3.  Parasite Killing of Leishmania (V) braziliensis by Standardized Propolis Extracts.

Authors:  Jéssica Rebouças-Silva; Fabiana S Celes; Jonilson Berlink Lima; Hernane S Barud; Camila I de Oliveira; Andresa A Berretta; Valéria M Borges
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-13       Impact factor: 2.629

4.  Chemical characterization and biological activity of six different extracts of propolis through conventional methods and supercritical extraction.

Authors:  Danielle Devequi-Nunes; Bruna Aparecida Souza Machado; Gabriele de Abreu Barreto; Jéssica Rebouças Silva; Danielle Figuerêdo da Silva; José Luiz Carneiro da Rocha; Hugo Neves Brandão; Valéria M Borges; Marcelo Andres Umsza-Guez
Journal:  PLoS One       Date:  2018-12-04       Impact factor: 3.240

Review 5.  The Strong Anti-Kinetoplastid Properties of Bee Propolis: Composition and Identification of the Active Agents and Their Biochemical Targets.

Authors:  Godwin U Ebiloma; Nahandoo Ichoron; Weam Siheri; David G Watson; John O Igoli; Harry P De Koning
Journal:  Molecules       Date:  2020-11-05       Impact factor: 4.411

6.  Brazilian propolis antileishmanial and immunomodulatory effects.

Authors:  Suelen Santos da Silva; Graciele da Silva Thomé; Allan Henrique Depieri Cataneo; Milena Menegazzo Miranda; Ionice Felipe; Célia Guadalupe Tardeli de Jesus Andrade; Maria Angélica Ehara Watanabe; Gilce Maria Piana; José Maurício Sforcin; Wander Rogério Pavanelli; Ivete Conchon-Costa
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-16       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.